HealthDay News — Under the Physician Payments Sunshine Act, physicians have only a few weeks left to review and report disputes relating to their financial ties to drug and medical device manufacturers, according to the American Medical Association.

The Centers for Medicare & Medicaid Services (CMS) announced the start of a 45-day review and dispute period, which will end on May 15, 2016. Disputes filed during this time will be flagged in the Open Payment data prior to publication of the 2015 data. Disputes submitted after the deadline will not be flagged for the initial release.

The Open Payments program has been established to increase transparency and accountability within health care, but has seen issues with inaccurate data. In order to dispute any inaccurate data reported, physicians must complete the CMS e-verification process, register with the Open Payments system, and review data and dispute any inaccuracies. Any disputes can be followed through the portal from initiation to resolution.

“Physicians have three weeks left to review and dispute reports regarding their financial interactions with manufacturers of drugs and medical devices reported under the Physician Payments Sunshine Act, also known as the Open Payments program,” according to the article.

More Information